First injection and current risk factors for HIV among new and long-term injection drug users

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 12, Issue 3, 2000, Pages 313-320

  Chitwood, Dale D ^b   Sanchez, J ^c   Comerford, M ^c   Page, J B ^c   McBride, D C ^a   Kitner, K R ^c  

^a ANDREWS UNIVERSITY   (United States)

^b Department of Biology   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE;

ADULT; CONFERENCE PAPER; FEMALE; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UNITED STATES;

EID: 0033917348     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120050042972     Document Type: Conference Paper

References (17)

1. BOOTH, R.E., KWIATKOWSKI, C.F., IGUCHI, M.Y., PINTO, D. & JOHN, D. (1998). Facilitating treatment entry among out-of-treatment injection drug users. Public Health Reports, 113, 116-129.
2. BORTOLOTTI, F., STIVANELLO, A., DALL'ARMI, A., RINALDI, R. & LA GRASTA, F. (1988). AIDS information campaign has significantly reduced risk factors for HIV infection in Italian drug abusers. Journal of AIDS, 1, 412-413.
3. D'AQUILA, R.T., PETERSON, L.R., WILLIAMS, A.B. & WILLIAMS, A.E. (1989). Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users. Journal of AIDS, 2, 503-511.
4. DE ROSSI, A., BORTOLOTTI, F., CADROBBI, P. & CHIECO-BIANCHI, L. (1988). Trends of HTLV-1 and HIV infections in drug addicts. European Journal of Cancer and Clinical Oncology, 24, 279-280.
5. DES JARLAIS, D.C., FRIEDMAN, S.R., PERLIS, T., CHAPMAN, T.F., SOTHERAN, J.L., PAONE, D., MONTERROSO, E. & NEAIGUS, A. (1999). Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 67-72.
6. FRIEDMAN, S.R., DES JARLAIS, D.C., NEAIGUS, A., ABDUL-QUADER, A., SOTHERAN, J.L., SUFIAN, M., TROSS, S. & GOLDSMITH, D. (1989). AIDS and the new drug injector. Nature, 39, 33-34.
7. HOLMBERG, S. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86(5), 642-654.
8. INCIARDI, J.A. & PAGE, J.B. (1991). Drug sharing among intravenous drug users. AIDS, 5, 772-773.
9. METZGER, D.S., WOODY, G., MARMOR, M. & GROSS, M. (1996). Risk characteristics of injection drug users (IDUs) participating in the vaccine preparedness study (VPS). Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada.
10. NEAIGUS, A., FRIEDMAN, S., JOSE, B., GOLDSTEIN, M., CURTIS, R. & DES JARLAIS, D.C. (1993). Risk factors for HIV infection among new drug injectors. Presented at the IXth International Conference on AIDS, Berlin.
11. NELSON, K.E., VLAHOV, D., SOLOMON, L., COHN, S. & MUNOZ, A. (1995). Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Maryland. Archives of Internal Medicine, 155, 1305-1311.
12. PROCHASKA, J.O. & DI CLEMENTE, C.C. (1982). Transtheoretical therapy: toward a more integrative model of change. Psychotherapy Theory, Research and Practice, 20, 161-173.
13. STULL, D.D. & ERICKSON, K.C. (1998). Doing team ethnography. Thousand Oaks, CA: Sage.
14. VAN AMEIJDEN, E.J., VAN DEN HOEK, J.A.R., VAN HAASTRECHT, H.J.A. & COUTINHO, R.A. (1992). The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users in Amsterdam. American Journal of Epidemiology, 136, 236-244.
15. VAN AMEIJDEN, E.J., VAN DEN HOEK, J.A.R., HARTGERS, C. & COUTINHO, R.A. (1994). Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. American Journal of Epidemiology, 139, 1153-1163.
16. VLAHOV, D., MUNOZ, A., ANTHONY, J.C., COHN, S., CELENTANO, D.D. & NELSON, K.E. (1990). Association of drug injection patterns with antibody to human immunodeficiency virus type I among intravenous drug users in Baltimore, Maryland. American Journal of Epidemiology, 132, 847-856.
17. VLAHOV, D., ANTHONY, J.C., CELENTANO, D., SOLOMON, L. & CHOWDHURY, N. (1991). Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. American Journal of Drug Abuse, 17, 39-48.